Tonbo Imaging India Shares Rise 20 Per Cent, Surge 119 Per Cent Since Listing

Tonbo Imaging India has witnessed a significant rally in its shares. According to a report by Business Standard, the company's shares surged 20 per cent on the BSE. With this increase, the share price has reached a new high of ₹1,533.65. Notably, over the last 2 weeks, the stock has recorded a massive jump of 119 per cent against its issue price.

Meanwhile, a general bullish trend was observed in the Indian stock market. As per a report by Amar Ujala, the Sensex closed at 77,219.65 on Wednesday, gaining over 350 points, while the Nifty closed at 23,911.70, crossing the 23,900 mark. The Sensex rose by 301.80 points (0.39 per cent) and the Nifty by 100.86 points (0.42 per cent). This rally was attributed to the impact of the US midterm election results, where the Democratic Party showed signs of a 'blue sweep' by securing a majority in the Senate and the House of Representatives.

Across various market sectors, the Nifty Realty Index saw a major jump of 2 per cent. The Nifty FMCG and Consumer Durables indices gained more than 1 per cent, although a decline was seen in the Nifty IT Index. In the broader markets, the Nifty Smallcap 250 and Nifty Midcap 100 indices rose by up to 0.75 per cent. Global markets showed a mixed response, with Hong Kong's Hang Seng rising 1.3 per cent and Shanghai Composite increasing 1.9 per cent, while Japan's Topix fell 0.9 per cent.

Based on a report from Choice Institutional, TV9 Gujarati has suggested 5 strong shares for investors. A target price of ₹715 has been given for Bajaj Consumer Care, which could yield a profit of 90.7 per cent from the current price of ₹385.25. In the defence sector, Garden Reach Shipbuilders and Engineers (GRSE) has a target of ₹3,500, indicating a 71 per cent upside from the current price of ₹2,131. In housing finance, a target of ₹330 has been set for Aptos Value Housing Finance (current price ₹201.71), and in hospitality, a target of ₹240 for Samahi Hotels (current price ₹153.99). In the IT sector, a target price of ₹1,185 has been set for RateGain Travel Technologies, which could offer a return of 47.1 per cent from the current price of ₹820.25.

Regarding corporate results, according to Business Standard, Emcure Pharma's net profit for the second quarter (Q2FY27) increased by 29.31 per cent to ₹325 crore, compared to ₹251.37 crore during the same period last year. Additionally, as per a report by The Times of India, Alembic Pharmaceuticals' Q2 PAT rose 81 per cent to ₹335 crore.